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Pancreatic growth factorFor growth factors, cytokines, G-protein-coupled receptors and numerous other stimuli, the Src Family of ki-
nases (SFK) play a central signaling role. SFKs also play an important role in pancreatic acinar cell function
including metabolism, secretion, endocytosis, growth and cytoskeletal integrity, although the speciﬁc SFKs
involved are not fully known. In the present study we used speciﬁc antibodies for the SFK, Yes, to determine
its presence, activation by pancreatic secretagogues or growth factors, and interaction with cellular signaling
cascades mediated by CCK in which Yes participates in to cause acinar cell responses. Yes was identiﬁed in
acini and secretagogues known to activate phospholipase C (PLC) [CCK, carbachol, bombesin] as well as
post-receptor stimulants activating PKC [TPA] or mobilizing cellular calcium [thapsigargin/calcium ionophore
(A23187)] each activated Yes. Secretin, which activates adenylate cyclase did not stimulate Yes, nor did pan-
creatic growth factors. CCK activation of Yes required both high- and low-afﬁnity CCK1-receptor states. TPA-/
CCK-stimulated Yes activation was completely inhibited by thapsigargin and the PKC inhibitor, GF109203X.
CCK/TPA stimulated the association of Yes with focal adhesion kinases (Pyk2, FAK) and its autophos-
phorylated forms (pY397FAK, pY402Pyk2). Moreover, CCK/TPA stimulated Yes interacted with a number of
other signaling proteins, including Shc, PKD, p130Cas, PI3K and PTEN. This study demonstrates that in rat
pancreatic acini, the SFK member Yes is expressed and activated by CCK and other gastrointestinal
hormones/neurotransmitters. Because its activation results in the direct activation of many cellular signaling
cascades that have been shown to mediate CCK's effect in acinar cell function our results suggest that it is one
of the important pancreatic SFKs mediating these effects.
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.V.1. Introduction
The Src Family of kinases (SFK) play a central signaling role for
growth factors, cytokines and G protein-coupled receptors [1]. The
SFKs are also important in the signaling in many cellular processes
such as cell secretion, endocytosis, growth, cytoskeletal integrity
and apoptosis [1] which are mediated by these stimuli.
In pancreatic acinar cells the SFKs play an important role in en-
zyme secretion, membrane recycling, endocytosis, apoptosis, protein
synthesis in regulating calcium cellular levels, in regulation of PKCs,
in pancreatic acinar cell responses to injuries such as pancreatitis
and in maintaining cytoskeletal organization [2–8]. Various studies
report that of the nine SFKs [1], pancreatic acinar cells possess Yes
[4,7,9], Lyn [6,7,9] and in some studies [4,9], but not others [7],
pp60Src. Whereas the speciﬁc participation of Lyn in various cellular
processes stimulated by gastrointestinal hormones/neurotransmitters
and pancreatic growth factors in pancreatic acinar cells has been stud-
ied in detail [9], there is only limited information about the ability of
these stimulants to activate pp60Src and Yes and even less information
on their ability to stimulate different cellular pathways that have been
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atic acinar cell function.
To address this question in the case of the SFK, Yes, in the present
study we sought to determine whether activation of the SFK, Yes, is
involved in mediating the cellular signaling of gastrointestinal hor-
mones/neurotransmitters and of various gastrointestinal growth fac-
tors, which are known to alter pancreatic acinar cell function. We also
sought to determine in pancreatic acinar cells whether these stimula-
tory effects have possible interactions with other signaling proteins
that are reported to participate in different cellular processes. The
pancreatic acini are a very useful model to examine these issues as
they have been reported to be highly responsive to many gastrointes-
tinal hormones/neurotransmitters and growth factors which alter
pancreatic acinar function and have been used to study effects of
these stimulants on cell signaling cascades [3,6,9–12].
2. Materials and methods
2.1. Materials
Male Sprague–Dawley rats (150–250 g) were obtained from the
Small Animals Section, Veterinary Resources Branch, National Insti-
tutes of Health (NIH), Bethesda, MD. Rabbit anti-phospho-Src family
(Tyr416), rabbit anti Src family, rabbit phospho-Pyk2 (Tyr402), rabbit
anti-Pyk2, rabbit phospho-FAK (Tyr397), rabbit anti FAK, rabbit
anti-protein kinase δ (PKCδ), rabbit phospho-PKCδ (Tyr311), rabbit
phospho Shc (Tyr239/240), rabbit anti Shc, rabbit phospho-PKD
(Ser744/748), rabbit anti-protein kinase D (PKD), rabbit anti phospho
p130Cas (Tyr 410), phospho p85 PI3K (tyr458), rabbit anti-RafA,
rabbit anti PTEN, rabbit anti-c-cbl, rabbit monoclonal anti-phospho
c-Raf (56A6) antibodies and nonfat dry milk were purchased from
Cell Signaling Technology, Inc. Rabbit p130CAS antibody, and anti-
rabbit-HRP-conjugate antibodies were from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). Mouse monoclonal anti-Yes was purchased from
BD Biosciences (San Jose, CA). Tris/HCl pH 8.0 and 7.5 were from
Mediatech, Inc. (Herndon, VA). 2-Mercaptoethanol, protein assay solu-
tion, sodium lauryl sulfate (SDS) and Tris/Glycine/SDS (10×)were from
Bio-Rad Laboratories (Hercules, CA). MgCl2, CaCl2, Tris/HCl 1 M pH
7.5 and Tris/Glycine buffer (10×) were from Quality Biological, Inc.
(Gaithersburg, MD). Minimal essential media (MEM) vitamin solution,
amino acids 100×, Dulbecco's phosphate buffered saline (DPBS), gluta-
mine (200 mM), Tris–Glycine gels, L-glutamine, and fetal bovine serum
(FBS) were from Invitrogen (Carlsbad, CA). COOH-terminal octapeptide
of cholecystokinin (CCK), hepatocyte growth factor (HGF), bombesin,
insulin-like growth factor 1 (IGF-1), basic ﬁbroblast growth factor
(bFGF), vasoactive intestinal peptide (VIP), endothelin and secretin
were from Bachem Bioscience Inc. (King of Prussia, PA). CCK-JMV-
180 (CCK-JMV) was obtained from Research Plus Inc., Bayonne,
NJ. Epidermal growth factor (EGF), thapsigargin, platelet-derived
growth factor (PDGF), vascular endothelial growth factor (VEGF)
and deoxycholic acid were from Calbiochem (La Jolla, CA). Carbachol,
insulin, dimethyl sulfoxide (DMSO), 12-O-tetradecanoylphobol-13-
acetate (TPA), 8-bromoadenosine 3′5′ cyclic monophosphate sodi-
um (8-Bromo-cAMP), L-glutamic acid, glucose, fumaric acid, pyruvic
acid, trypsin inhibitor, HEPES, TWEEN® 20, Triton X-100, GFX
(GFX109203X), phenylmethanesulfonylﬂuoride (PMSF), ethylene-
diaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid
(EGTA), sucrose, sodium-orthovanadate, sodium azide and
CelLytic™M Cell Lysis Reagent were from Sigma-Aldrich, Inc. (St.
Louis, MO). Albumin standard, Protein G agarose beads and Super
Signal West (Pico, Dura) chemiluminescent substrate were from
Pierce (Rockford, IL). Protease inhibitor tablets were from Roche
(Basel, Switzerland). Puriﬁed collagenase (type CLSPA) was from
Worthington Biochemicals (Freehold, NJ). Nitrocellulose mem-
branes were from Schleicher and Schuell Bioscience, Inc. (Keene,
NH). L-364,718 (3S(−)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4 -benzodiazepine-3 -yl -1H- indole -2-carboxamide)) and L-
365,260 (3R(+)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-
benzodiazepin3-yl)-N′-(3-methylphenyl)urea) were from Merck,
Sharp and Dohme (West point, PA). YM022 ((R)-1-[2,3-dihydro-1-
(2′-methyl-phenacyl)‐2‐oxo‐5-phenyl-1H-1,4-benzodiazepin‐3-yl]-3-
(3-methylphenyl)urea) and SR27897 (1-[[2-(4-(2-chlorophenyl)-
thiazol-2-yl)aminocarbonyl] indolyl]acetic acid) were from Tocris
Bioscience (Ellisville, MO). Biocoat collagen I Cellware 60 mm dishes
were from Becton Dickinson Labware (Bedford, MA). Albumin bo-
vine fraction V was from MP Biomedical (Solon, OH). NaCl, KCl and
NaH2PO4 were from Mallinckrodt (Paris, KY).
2.2. Methods
2.2.1. Tissue preparation
Pancreatic acini were obtained by collagenase digestion as previ-
ously described [12]. Standard incubation solution contained
25.5 mM HEPES (pH 7.45), 98 mM NaCl, 6 mM KCl, 2.5 mM
NaH2PO4, 5 mM sodium pyruvate, 5 mM sodium glutamate, 5 mM so-
dium fumarate, 11.5 mM glucose, 0.5 mM CaCl2, 1 mM MgCl2, 1 mM
glutamine, 1% (w/v) albumin, 0.01% (w/v) trypsin inhibitor, 1%
(v/v) vitamin mixture and 1% (v/v) amino acid mixture.
2.2.2. Acini stimulation
After collagenase digestion, dispersed acini were pre-incubated
in standard incubation solution for 2 h at 37 °C with or without in-
hibitors as described previously [12,13]. After pre-incubation 1 ml
aliquots of dispersed acini were incubated at 37 °C with or without
stimulants. Cells were lysed in lysis buffer (50 mM Tris/HCl pH 7.5,
150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% sodium
azide, 1 mM EGTA, 0.4 mM EDTA, 0.2 mM sodium orthovanadate,
1 mM PMSF, and one protease inhibitor tablet per 10 ml). After son-
ication, lysates were centrifuged at 10,000×g for 15 min at 4 °C and
protein concentration was measured using the Bio-Rad protein
assay reagent.
2.2.3. Immunoprecipitation
Immunoprecipitation of tyrosine phosphorylated proteins was per-
formed as described previously [11]. For detection of Yes, 1 mg/ml of
whole acinar lysate was incubated with 4 μg BD Yes antibody and
25 μl of protein G agarose beads overnight at 4 °C. Immuno-
precipitates were washed once with lysis buffer and twice in phos-
phate buffered buffer 0.2 mM sodium orthovanadate and analyzed
by SDS-PAGE and Western blotting.
2.2.4. Co-immunoprecipitation (Co-IP)
After stimulation, acini were washed with ice-cold phosphate-
buffered saline, and then resuspended in 1 ml of CelLytic Buffer
(CelLytic™M Cell Lysis Reagent 0.2 mM sodium orthovanadate,
1 mM PMSF, and one protease inhibitor tablet per 10 ml), mixed
for 20 min at 4 °C and centrifuged for 15 min, 12,000×g. Superna-
tant containing the solubilized protein complexes was kept at
−80 °C until protein determination by Bio-Rad protein assay re-
agents. For Co-IP studies, lysates (750 μg/μl) were incubated with
4 μg of the BD antibody and with 25 μl of protein G-agarose at 4 °C,
overnight. The immunoprecipitates were washed once with CelLytic
buffer and twice with phosphate-buffered saline and analyzed by
SDS-PAGE and Western blotting.
2.2.5. Western blotting
Western blotting was performed as described previously [11,14].
The intensity of the protein bands was measured using Kodak ID
Image Analysis, which were assessed in the linear detection range.
When re-probing was necessary membranes were incubated in Strip-
ping buffer (Pierce, Rockford, IL) for 30 min at room temperature,
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ing buffer at room temperature and re-probed as described above.
2.2.6. Statistical analysis
All experiments were performed at least 3 times. Data are pres-
ented as mean±SEM and were analyzed using the one-way ANOVA
analysis with Dunnett's or Bonferroni multiple test as posttests
using the GraphPad 5.0 software. p values b0.05 were considered sig-
niﬁcant. Curve ﬁtting, EC50 and tmax were also calculated using the
GraphPad 5.0 software.
3. Results
3.1. Speciﬁcity of the antibodies used in the study
In order to check the speciﬁcity of the antibodies to be used in this
study, whole pancreatic acinar lysates, in parallel with human recom-
binant samples of the 3 SFK family members found in pancreatic
acinar cells (Lyn, Yes, and Src) and the related SFK, Fyn, were immu-
noprecipitated with 4 μg anti-Yes BD monoclonal antibody and
detected with pY416 Src family antibody (Fig. 1, Panel B, Cell Signal-
ing: CS) or total Yes Ab (Fig. 1, Panel A, CS). We observed a signal
only in the lane corresponding to the Yes kinase human recombinant
(Fig. 1).
3.2. Ability of various pancreatic secretagogues but not pancreatic
growth factors to stimulate Yes phosphorylation (pY416) in rat
pancreatic acini
In order to establish whether Yes kinase is activated by known
pancreatic secretagogues or growth factors [10], rat pancreatic acini
were incubated in the absence and presence of several gastrointesti-
nal hormones (CCK, carbachol, bombesin, secretin, VIP) known to ac-
tivate pancreatic acinar cells and cause enzyme secretion [10]. As a
measurement of Yes activity the phosphorylation of Y416 of YesFig. 1. Speciﬁcity of the antibodies used in the study. Lysates from pancreatic acini and
equal amounts of human recombinant Src family members present in the pancreatic aci-
nar cells (Lyn, Yes, and Src) or the related SFK, Fyn were immunoprecipitated (IP) in par-
allelwith 4 μg of anti-Yes BDantibody and the resultant immunocomplexeswere detected
byWestern blotting (WB)with a speciﬁc anti-Yes antibody (Cell signaling= CS), Panel A;
or with a speciﬁc anti-pY416 Src family antibody (Cell signaling), Panel B.was assessed. Numerous studies show that all members of the Src
family share 2 tyrosine phosphorylation sites, one at Y416 that causes
the activation of these kinases and the other one, Y527 that produces
their inhibition [1]. The pancreatic secretagogues that activate phos-
pholipase C (CCK, carbachol, bombesin) stimulated an increase in
Yes phosphorylation in tyrosine 416 (pY416) (334±53, 207±28,
213±17% of control, respectively, all pb0.05 vs control) (Fig. 2,
Panel A, Rows 4–6; Table 1). Secretin and VIP, which activateFig. 2. Ability of various pancreatic secretagogues and pancreatic growth factors to
stimulate Yes phosphorylation (pY416) in rat pancreatic acini. Panel A: Activation
of pY416 Yes induced by CCK (100 nM), carbachol (10 μM), bombesin (1 nM), secre-
tin (10 nM), VIP (10 nM) in isolated pancreatic acini. Isolated pancreatic acini were
incubated with the indicated agents for 1 min, and then lysed. Yes kinase was immu-
noprecipitated as established in Materials and methods and Western blots were an-
alyzed using anti-pY416 Src family and, as loading control, anti-Total Yes. Bands
were visualized using chemiluminescence and quantiﬁed by densitometry. Top: Re-
sults of a representative blot of 6 independent experiments are shown. Bottom:
Means±S.E. of 6 independent experiments. Results are expressed as % of basal stim-
ulation of the control group taking total Yes as a loading control. *pb0.05 compared
to the control group. Panel B: Action of CCK (100 nM, 1 min), insulin (1 μM, 10 min),
EGF (10 nM, 5 min), PDGF (100 ng/ml, 10 min), bFGF (100 ng/ml, 5 min), IGF
(100 nM, 10 min) and HGF (1 nM) upon the activation of Yes in the pancreatic
acini. The experiment was performed as described in Panel A above. Results of a rep-
resentative blot of 6 independent experiments are shown. *pb0.05 compared to the
control group. Panel C: Isolated pancreatic acini were incubated in the absence or
presence of CCK (100 nM), gastrin (10 nM) or A71378 (30 nM) for 1 min, or pre-
incubated for 5 min in the presence of L364,718 (1 μM), YM022 (1 μM), L365,260
(1 μM) or SR27897 (1 μM) and then in the additional presence of CCK (100 nM) for
1 min. Yes kinase activity was determined as established in Materials and methods.
Table 1
Y416 Yes Kinase Phosphorylation characteristics and interactions of Yes in rat pancre-
atic acinia.
Variable pY416 phosphorylation
Stimulation by pancreatic secretagoguesb
Yes CCK, carbachol, bombesin,
No Secretin, Endothelin-1, VIP
Stimulation by pancreatic growth factorsb
Yes –
No Insulin, EGF, PDGF, bFGF, IGF-1, HGF
Stimulation by post-receptor activators
Yes A2387, Thapsigargin, TPA
No 8-Bromo-cAMP
Potency/time-course
EC50 of CCK (nM)c 2.11±0.15
EC50 of CCK-JMV (nM)c 19.45±1.19
t1/2 of CCK (min)d 0.31±0.04
tmax of CCK (min)d 0.98±0.14
t1/2 of TPA (min)e 1.25±0.24
tmax of TPA (min)e 2.49±0.29
Interactions with other kinases
Co-immunoprecipitation withf,g,h PYK2, p125FAK, p130Cas, Shc,
PKD, PKCδ, PI3K, PTEN
a Results are calculated from the data shown in Figs. 2–8.
b Concentration and incubation times are reported in Fig. 2.
c Concentrations and incubation times are reported in Fig. 3.
d Concentration and incubation times are reported in Fig. 4.
e Concentration and incubation times are reported in Fig. 5.
f Concentration and incubation times are reported in Fig. 6.
g Concentration and incubation times are reported in Fig. 7.
h Concentration and incubation times are reported in Fig. 8.
Fig. 3. Dose–response effect of CCK and CCK-JMV on Yes kinase phosphorylation in rat
pancreas acini. Experiments were performed as described in Fig. 1 legend and Materials
and methods. Top: Results of a representative blot of 5 independent experiments are
shown. Bottom: Means±S.E. of 5 independent experiments. Results are expressed as %
of maximal CCK stimulation (CCK 100 nM: 280±16% of control). *pb0.05 compared to
the control group.
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phorylation of Yes Y416 (Fig. 2, Panel A, Rows 2 and 3; Table 1).
Endothelin-1 (ET-1), which interacts with ET-1 and ET-3 receptors
in the pancreatic acinar cell, but does not activate PLC cascades nor
activate adenylate cyclase [15] did not produce a signiﬁcant incre-
ment in Y416 Yes phosphorylation (Fig. 2, Panel A, Row 7; Table 1).
None of the known pancreatic growth factors tested (insulin,
EGF, PDGF, bFGF, IGF, and HGF) [10] was able to activate Yes kinase
and stimulate tyrosine 416 phosphorylation of Yes (Fig. 2, Panel B,
Rows 1–7; Table 1). This lack of stimulation was not due to the in-
ability of the growth factors to activate acinar cells because each
stimulated pS473 Akt phosphorylation (data not shown).
In order to determine if the CCK stimulating effect on pY416 Yes
phosphorylation was due to the presence/activation of CCK1 or CCK2
receptors in the acinar cell suspension, isolated acinar cells were ﬁrst
incubated with either CCK, gastrin, or a known CCK1 receptor agonist
(A71378) [16] (Fig. 2, Panel C, Lanes 1–4). Gastrin did not produce
any increase in pY416 Yes phosphorylation, and the CCK activation
of Yes was mimicked by the incubation of the cells with the selective
CCK1 receptor agonist, A71378. Moreover, when the acinar cells
were incubated with CCK and two different CCK1 receptor antago-
nists [L364,718 or SR27897] [17,18] the increment in pY416 Yes
phosphorylation observed in the sole presence of CCK was largely
inhibited, but not in the presence of CCK2 receptor antagonists
[L365,260 or YM022] [18] (Fig. 2, Panel C, Lanes 5–10). These results
demonstrate that the observed effect of CCK in pY416 Yes phosphor-
ylation is only due to the activation of the CCK1 receptors.
3.3. Dose–response effect of CCK and CCK-JMV on Yes kinase Y416
phosphorylation in rat pancreatic acini
As CCK has an important role in both the physiology and patho-
physiology of the pancreas [10,19], we focused our study in the acti-
vation of Yes kinase exerted by this hormone in rat pancreaticacini. Increasing concentrations of CCK produced a monophasic in-
crease in Y416 phosphorylation of Yes, detectable at 0.01 nM con-
centration (Fig. 3), maximal stimulation occurred with 100 nM CCK
(280±16% of control) and CCK's half-maximal effect (EC50) occurred
with 2.11 nM±0.15 nM (Fig. 3, Table 1). The CCK1 receptor in pan-
creatic acini can exist in two different activation states, a low and a
high-afﬁnity state, and the activation of the different states activates
different cell signaling cascades [20–22]. In order to determine the
contribution of each activation receptor state to the activation of
Yes kinase by CCK, pancreatic acini were incubated in the presence
of increasing concentrations of CCK-JMV, known to be an agonist of
the CCK1 high afﬁnity state and an antagonist of the low afﬁnity
CCK1 receptor state in the rat pancreatic acini [20,22,23]. CCK-JMV
stimulated tyrosine 416 phosphorylation of Yes kinase in a monoph-
asic manner with concentrations from 100 nM to 1000 nM (Fig. 3)
with an EC50 of 19.45±1.19 nM (Fig. 3, Table 1), and therefore was
9 times less potent than CCK. CCK-JMV caused 63% of the maximal
stimulation of pY416 Yes phosphorylation caused by CCK (Fig. 3).
These results support the conclusion that CCK stimulation of Yes
kinase activation is mediated 60% by the high afﬁnity state CCK1
receptor and 40% by activation of the low afﬁnity CCK1 receptor
state. As a CCK concentration of 100 nM produces the maximal stim-
ulation of Yes phosphorylation, it was selected for use in the next
part of the study.
3.4. Time course of CCK and TPA stimulation of Yes kinase Y416
phosphorylation in rat pancreatic acini
Stimulation of Yes pY416 by CCK was time-dependent, with a sig-
niﬁcant increment after 30-second incubation time (278±27% of
control, pb0.05), and maximum after 1 min (310±43% of control,
pb0.05) (Fig. 4), with t1/2 of 0.309±0.042 min (Table 1). The in-
crease in phosphorylation of pY416 Yes by CCK was maintained in
time and lasted over 15 min (all pb0.05) (Fig. 4).
Because phospholipase C (PLC) stimulating pancreatic hormones,
which subsequently activate PKC, stimulated Yes Y416 phosphoryla-
tion, the ability of TPA, a known PKC activator, to stimulate Yes
Y416 phosphorylation at different times, was studied (Fig. 4). TPA
produced, as in the case of CCK, a rapid increase (1 min: 153±25%
of control) in Yes kinase pY416 phosphorylation (Fig. 4), maximum
Fig. 4. Time course of CCK and TPA stimulation of Yes pY416 phosphorylation in rat
pancreatic acini. Experiments were performed as described in Fig. 1 legend andMaterials
and methods. Top: Results of a representative blot of 7 independent experiments are
shown. Bottom: Means±S.E. of 7 independent experiments. Results are expressed as %
of basal stimulation of the control group. *pb0.001 compared to the control group (i.e.
0 time).
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0.24 min (Table 1), and the increase was maintained for 15 min.
TPA stimulation of Yes kinase pY416 phosphorylation was delayed
in time compared to the CCK time course, likely due to the fact that
TPA has to cross the cell's plasma membrane prior to PKC activation.
3.5. Effect of post-receptor stimulants, PKC inhibition or Ca2+ depletion
on Y416 Yes kinase phosphorylation by CCK and TPA
When the ability of post-receptor stimulants to stimulate tyrosine
416 phosphorylation of Yes was tested, the PKC activating agent (TPA)
produced a signiﬁcant increment in tyrosine 416 phosphorylation of
Yes (TPA=202±34% of control pb0.05). However, the apparent in-
crease of Yes phosphorylation induced by the cellular calcium-
mobilizing agent, thapsigargin (TG) did not reach statistical signiﬁ-
cance (171±14% of control). The calcium ionophore A23187 and the
AMP cyclic analog 8-Br-cAMP did not stimulate Yes (137±18% or
116±11% of control, respectively). The combination of the calcium
mobilization agent (thapsigargin) with a PKC activator did not cause
a greater activation than the addition of these two agents alone
(Fig. 5, Panel A, Rows 3, 4, 6; Table 1). On the other hand, the combi-
nation of the calcium ionophore (A23187) with the PKC activator
(TPA) increased signiﬁcantly the activation of Yes as compared with
the addition of these two agents alone (pb0.05) (Fig. 5, Panel A,
Rows 2, 3, 5; Table 1).
We next examined whether CCK-induced activation of PKC or
increase in intracellular calcium was needed for its ability to
cause pY416 tyrosine phosphorylation of Yes in pancreatic acini
(Fig. 5, Panel B, Rows 1–6). To determine the role of intracellular
calcium changes [Cai], pancreatic acinar cells were pretreated for
1 h in a calcium-free medium with thapsigargin (10 μM), an agent
that speciﬁcally inhibits the endoplasmic reticulum Ca2+-ATPase
and depletes calcium from intracellular compartments in a calcium
free medium [12]. These conditions have been previously shown to
completely inhibit the [Ca2+i] increase stimulated by CCK in rat
pancreatic acinar cells [12]. In order to examine the implication of
PKC in the CCK stimulated tyrosine 416 Yes phosphorylation, isolat-
ed acinar cells were treated for 1 h with a general PKC inhibitor
GFX109203X [12] prior to incubation with CCK or TPA.
When PKCs activation was inhibited, no increment in the tyro-
sine phosphorylation of Yes was produced by CCK or TPA (CCKalone: 293±24% of control, pb0.05 vs control; CCK+GFX: 139±21%
of control, pb0.05 vs CCK alone; TPA alone: 369±41% of control,
pb0.05 vs control; TPA+GFX: 93±4% of control, pb0.05 vs TPA
alone) (Fig. 5, Panel B, Rows 1–6). Inhibition of increments in intracellu-
lar Ca2+ produced a signiﬁcant decreased in the pY416 tyrosine phos-
phorylation of Yes by CCK (CCK alone: 261±32% of control, pb0.05 vs
control; TG+CCK: 146±11% of control, pb0.05 vs CCK alone) or TPA
(TPA alone: 393±76% of control, pb0.05 vs control; TG+TPA: 174±
20% of control, pb0.05 vs TPA alone) (Fig. 5, Panel B, Rows 7–12).
3.6. Ability of CCK and TPA to stimulate the association of Yes kinase with
various cellular proteins in rat pancreatic acinar cells
Src kinases are reported to interact with a number of other impor-
tant cellular signaling proteins in different cell types including the
focal adhesion kinases p125FAK and PYK2 [1,9,24,25], PI3K [1], Cbl
[1], PKD [26], Raf [27] Shc [1,28], PKCδ [1], and p130Cas [1], PTEN
[29], kinases/phosphatases known to be particularly important in
regulating processes such as growth and apoptosis, adhesion or secre-
tion. In order to determine the possible interaction of Yes with these
proteins in the pancreatic acini, we studied the ability of CCK or TPA
to stimulate a direct interaction of Yes with these proteins by per-
forming co-immunoprecipitation (Co-IP) studies (Figs. 6–8). We
ﬁrst investigated the Co-IP of Yes kinase with the different proteins
after incubation with CCK (2.5 min, 100 nM) or TPA (5 min, 1 μM),
concentrations that caused a maximal Yes activation [CCK (100 nM)
(Fig. 3) and TPA (1 μM)]. We observed that CCK and TPA (Fig. 6–7,
Panel A–D, Rows 1–3, Lanes 1–3; Table 1) produced an increase in
the association of Yes with p125FAK and PYK2, PI3K, PKD, p130Cas,
Shc and the novel PKC kinases δ, but not with Raf, Cbl or ERK1/2
(data not shown). In order to determine if the Co-IP of Yes kinase
with these different proteins also occurred at more physiological con-
centrations of CCK, we performed the same type of CO-IP experi-
ments using CCK at concentrations of 100 pM and 1 nM (Fig. 8). We
observed that at both concentrations CCK (Fig. 8, Rows 1–3, Lanes
1–13; Table 1) produced an increase in the association of Yes with
PYK2, PI3K, PKD, p130Cas, Shc and the novel PKC kinases δ, but not
with p125FAK (Fig. 8, Row #3) (which did interact with Yes at higher
concentrations) (Fig. 6, Row #3, Panel A) or with Raf, Cbl or ERK1/2
(data not shown). To ensure that the antibody used for immuno-
precipitation was not the cause of lack of association, we repeated
the Co-IP experiments in the reverse direction: immunoprecipi-
tating with Raf, Cbl or ERK1/2 antibodies and immunodetection
with Yes antibodies, and we did not obtained any stimulated direct
association with Yes after incubation with CCK or TPA.
4. Discussion
In pancreatic acinar cells, Src family of kinases (SFKs) are
reported to be important for cell growth, to play an important role
in enzyme secretion, endocytosis, membrane recycling, apoptosis,
protein synthesis, regulation of calcium levels, regulation of PKCs
or in response to acinar cell injury, as occurs in pancreatitis
[3,4,6–9]. The SFK family consists of nine structurally related mem-
bers [1], of which 3 are reported in pancreatic acinar cells (Lyn,
pp60Src, Yes) [4,6,7,9,28], however little is known in pancreatic aci-
nar cells, except for the case of Lyn [9], of the individual SFK mem-
bers participation in the cellular signaling cascades mediating these
various pancreatic cellular processes.
The present study was designed to address the question of
whether the activation of the SFK, Yes, is involved in mediating the
cellular signaling of gastrointestinal hormones/neurotransmitters
and of various gastrointestinal growth factors that are known to
alter pancreatic acinar cell function. The presence of Yes and its spe-
ciﬁc activation was assessed by using a speciﬁc Yes antibody for
immunoprecipitating and the panSrc phospho-speciﬁc antibody
Fig. 5. Effect of post-receptor stimulants, PKC inhibition or Ca2+ depletion on pY416 Yes phosphorylation by CCK and TPA. Panel A: Effect of A23187 (1 μM), TPA (1 μM),
thapsigargin (TG) (1 μM), 8-Br-cAMP (1 mM) on Yes phosphorylation (at 5 min), and of CCK (100 nM), (at 1 min). Top: Results of a representative blot of 4 independent exper-
iments are shown. Bottom: Means±S.E. of 4 independent experiments. Results are expressed as % of basal stimulation of the control group. *pb0.05 compared to the control
group. Panel B: Isolated acini were preincubated for 2 h, alone or in the additional presence of GF109203X (5 μM, 30 min, Panel B Left) or thapsigargin (TG) (1 μM, 2 h, Panel B
Right) in calcium free media and then incubated with or without 100 nM CCK or 1 μM TPA for 1 or 2.5 min, respectively. Top: Results of a representative blot of 4 independent
experiments are shown. Bottom: Means±S.E. of 4 independent experiments. Results are expressed as % of basal stimulation of the control group. *pb0.05 compared to the control
group, #pb0.05 compared to the stimulant alone.
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Yes. This later ﬁnding is important because Y416 phosphorylation
reﬂects the degree of SFKs activation [1] and it has been widely
used to speciﬁcally assess SFK activation when combined with
speciﬁcally immunoprecipitating individual SFKs, such as Lyn or
pp60Src [9]. Our results demonstrate that the SFK, Yes is present
in pancreatic acini and that its activated pY416 form can be specif-
ically detected.
In this the present study we ﬁrst investigated the ability of various
pancreatic stimulants to activate Yes by assessing their ability to stim-
ulate pY416 tyrosine phosphorylation of Yes. Previous results have
demonstrated that numerous growth factors (HGF, EGF, bFGF, insulin,
IGF and PDGF) are able to interact with speciﬁc receptors on pancre-
atic acinar cells and stimulate growth and/or protein synthesis as well
as alter other cellular functions [10]. In our study, we used concentra-
tions that were able to activate Akt in acini, under identical experi-
mental conditions, that previous studies reported the particular
pancreatic growth factors we studied activated a number of pancreat-
ic acinar cell responses [9,10,14,20,23]. We did not observe activation
of Yes induced by any of these growth factors. This result contrasts
with a previous study in pancreatic acini in which, the SFK, Lyn was
activated by the same pancreatic growth factors used in the present
study [9]. Our results are similar with bFGF to a previous study in
pancreatic acinar cells in which bFGF was reported to not activateSFK in pancreatic acinar cells [3]. Our results have both similarities
and differences from studies in other tissues, reporting SFK activa-
tion by these growth factors [30]. EGF, PDGF, and bFGF activate the
SFK, cSrc in murine ﬁbroblasts [31], and in skeletal muscle cells insu-
lin stimulates SFK activation [32]. In ovarian cells insulin stimulates
Fyn activation [33]; in differentiating preadipocytes IGF stimulates
Src activation [34]; and EGF and PDGF stimulated activation of Yes
in hepatocytes and ﬁbroblasts in some studies [35,36]. The ability
of the growth factors to stimulate Lyn in the pancreatic acinar
cells, but not Yes, illustrates the potential for diversity in the func-
tion of the different isoforms of the SFKs in these cells. From stud-
ies in other tissues it has been concluded that cSrc and other SFKs
are activated in response to many of the same cellular signals, but
it is not always clear where Yes performs unique functions and
when it functions redundantly with other members of the Src fam-
ily of kinases [37]. In pancreatic acini, our results indicate that, un-
like the SFK Lyn [9], Yes, is not involved in the cellular response to
growth factors.
Our results show that pancreatic secretagogues which activate G
protein-coupled receptors on pancreatic acinar cells and stimulate
phospholipase C (PLC)-mediated cascades, [10], activate Yes in pan-
creatic acini. This was demonstrated by the fact that CCK, the musca-
rinic cholinergic agonist carbachol, and bombesin, each of which
interacts with speciﬁc G-protein coupled receptors on pancreatic
Fig. 6. Ability of CCK (100 nM) or TPA (1 μM) to stimulate the association of Yes ki-
nase with PYK2, p125FAK, PKCδ, and Shc. Isolated pancreatic acini were incubated in
the absence and presence of CCK (2.5 min) or TPA (5 min). Equal amounts of pro-
teins were immunoprecipitated with an anti-Yes (BD) and then subjected to Western
blotting, using as ﬁrst antibody anti-p125FAK, anti-PYK2, anti-PKCδ and anti-Shc or
anti-Src, total or phosphorylated form of the proteins. The bands were visualized
using chemiluminescence. Results are representative of 8 independent experiments.
Fig. 7. Ability of CCK (100 nM) or TPA (1 μM) to stimulate the association of Yes kinase
with PKD, p130Cas PI3K and PTEN. Isolated pancreatic acini were incubated in the ab-
sence and presence of CCK (2.5 min) or TPA (5 min). Equal amounts of proteins were
immunoprecipitated with an anti-Yes (BD) and then subjected to Western blotting,
using as ﬁrst antibody anti-PKD, anti-p130Cas, anti-PI3K, anti-PTEN or anti-Src, total
or phosphorylated form of the proteins. The bands were visualized using chemilumi-
nescence. Results are representative of 8 independent experiments.
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cium and PKC activation [10], each activated the SFK, Yes in pancreat-
ic acinar cells. However, other secretagogues stimulating PKA-
mediated pathways, or other signaling cascades like VIP, secretin or
endothelin, which interacts with GPCRs receptors on pancreatic
acini, but does not stimulate phospholipase C or adenylate cyclase
[15], did not activate the SFK, Yes in pancreatic acini. These results
have some similarities and differences from previous studies of the
ability of these GI hormones/neurotransmitters to activate SFKs in
pancreatic acini and other tissues. They are similar in that the SFK
Lyn was also activated in pancreatic acinar cells by bombesin, CCK,
and carbachol, however they differ from Lyn activation, which was
weakly stimulated by endothelin or secretin [9], whereas Yes in the
same cells is not. They are similar to a previous study which demon-
strated that supramaximal concentrations of CCK both stimulate ki-
nase activity of Yes, and also its phosphorylation [7]. In other
tissues, and in agreement with our study, bombesin-related peptides
and muscarinic cholinergic agents activated SFKs [1], however, in
other studies and in contrast to our results, secretin also activated
the SFKs [1], which is different from our results with Yes in pancre-
atic acinar cells. Also, in contrast to our results, endothelin activates
SFKs in different cells in some studies [38,39] however, in endothe-
lial cells endothelin activated the SFK Fyn, but Src and Hck were
inhibited and Yes was unaltered [40]. These results demonstrate
that the different SFKs are activated differentially by pancreatic se-
cretagogues/neurotransmitters in acinar cells and also that theability of a given gastrointestinal secretagogue/neurotransmitter to
activate SFKs can differ in different tissues.
To provide a greater insight into the interaction of the SFK, Yes, with
important cellular cascades mediating the action of pancreatic secreta-
gogues/neurotransmitters, the hormone/neurotransmitter CCK, which
is a physiological regulator of the pancreatic acinar cell function [41]
and has been reported to stimulate SFKs in pancreatic acinar cells and
other tissues [2,7,8,12,28], was investigated in detail. We found that
CCK causes a rapid activation of Yes which is similar to that reported
for its ability to activate Lyn or Yes in pancreatic acini in other studies
[7,9]. However, the kinetics of Yes activation differed from other studies
[7,9], because we found sustained Yes activation lasting up to 15 min,
whereas in the other studies, activation of SFKs by CCK, rapidly de-
creased with time [7,9]. In various tissues, activation of CCK1 and CCK2
receptors stimulates activation of various SFKs [6,9,42–44]. Our results
demonstrate that CCK activation of Yes in pancreatic acini was due
only to CCK1 receptor activation and not to CCK2 receptors that could
be present in accompanying cells or possibly on acini. CCK2 receptors
are reported in pancreatic acinar cells from other species and in the
rat pancreatic acinar cell line AR42J, CCK is reported to activate Yes
through CCK2 receptors [10,45,46]. However, our results demonstrate
Fig. 8. Ability of low concentrations of CCK (100 pM, 1 nM) to stimulate the associa-
tion of Yes kinase with PYK2, p130Cas, Shc, PKD, PKCδ, PI3K and PTEN. Isolated pan-
creatic acini were incubated in the absence and presence of the indicated
concentration of CCK for 2.5 min. Equal amounts of proteins were immuno-
precipitated with an anti-Yes (BD) and then subjected to Western blotting, using as
ﬁrst antibody anti-p125FAK, anti-PYK2, anti-PKCδ, anti-Shc, anti-PKD, anti-p130Cas,
anti-PI3K, anti-PTEN or anti-Src, total or phosphorylated form of the proteins. The
bands were visualized using chemiluminescence. Results are representative of 4 inde-
pendent experiments.
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the CCK receptor subtype mediating Yes activation.
Numerous studies demonstrate that CCK can activate both a high
and low afﬁnity receptor state, which can mediate different cellular
responses [12,47,48]. A number of our results support the conclusion
that full activation of Yes by CCK requires activation of both CCK1 re-
ceptor states. In our study, the CCK dose–response curve for Yes acti-
vation extended over concentration ranges that CCK activates both
high and low afﬁnity receptor states [10], suggesting activation of
both CCK1 receptor states, are involved in Yes activation. This conclu-
sion is supported by the results with the CCK-JMV, a synthetic CCK
analog, which stimulated only 64% of the maximal Yes activation cau-
sed by CCK-8. Because CCK-JMV in rat pancreatic acini functions as a
full agonist at the high afﬁnity receptor state and an antagonist of
the low afﬁnity state [22,48], our results demonstrate that 64% of
maximal Yes activation by CCK is due to activation of the high afﬁnity
CCK1 receptor state and 36% to activation of the low afﬁnity CCK1 re-
ceptor state. These results have similarities and differences from that
reported in other studies in pancreatic acini with CCK1 receptor-
mediated activation of SFK and other proteins. Similar to its mecha-
nism in the activation of Yes, CCK-induced activation of the SFK, Lyn
in pancreatic acini [9], is mediated by activation of both high and
low afﬁnity receptor states, as is the stimulation of the tyrosine phos-
phorylation of focal adhesion kinases (p125FAK, PYK2/CAβ) and their
phospho-speciﬁc sites [12,13], the scaffolding protein, paxillin [11,12]
and the novel PKC, pKCμ (PKD) [20]. However, the relative impor-
tance of activation of the high and low afﬁnity CCK1 receptor state dif-
fers among these proteins. In contrast to these results, CCK-mediated
activation in pancreatic acini of phospholipase D or PI3K requires ac-
tivation of only the high afﬁnity receptor state [49], whereas in thecase of PKC-δ [6] or CRK-II [50] only the low afﬁnity CCK1 receptor
state is required for activation. Also, in contrast to our results with Yes
activation, a previous study [3] reported that CCK-stimulated SFK activ-
ity is mediated almost entirely by activation of the low CCK1 receptor
state in pancreatic acini. Our results provide additional support to the
proposal [51] that not only are the different CCK1 receptor states on
pancreatic acini differentially coupled to activation of phospholipase
A2 and C [10], they are also differentially coupled to a number of tyro-
sine phosphorylation cascades including activation of the SFK, Yes.
Activation of the pancreatic CCK1 receptor stimulates phos-
pholipase C (PLC), resulting in the generation of inositol phosphates
and diacylglycerol which in turn results in mobilization of cellular
calcium and activation of PKCs, respectively [10,12]. A previous
study reported that activation of the two limbs of the PLC cascade
(PKC and calcium) in pancreatic acini and other cells by different
stimuli, can have effects on the phosphorylation of the SFK Lyn
[9]. A number of our results support the conclusion that in rat
pancreatic acini maximal activation of Yes by CCK requires activa-
tion of both limbs of the PLC cascade. First, thapsigargin, an agent
that increases cellular calcium acutely in a calcium-containing
medium, activated Yes. Second, direct activation of PKCs by the
phorbol ester TPA also activated Yes. Third, incubation with the
Ca2+ ATPase inhibitor, thapsigargin, under conditions which de-
plete cellular calcium resulting in complete inhibition of CCK-
mediated increases in [Ca2+]i in pancreatic acini, did not completely
inhibit CCK-stimulated Yes activation, resulting in a reduction of
71%. Furthermore, the PKC inhibitor, GF109203X, at a concentration
that inhibited TPA-stimulated tyrosine phosphorylation of other
non-receptor tyrosine kinases such as p125FAK and PYK2 [12,13] in
rat pancreatic acini, caused an 80% decrease in CCK-stimulated acti-
vation of Yes. These results have similarities and differences from
the role of PKC activation and/or changes in cytosolic calcium by
different stimulants in other cells on activation of SFKs. Similar to
the effect of CCK in pancreatic acini, PKC activation or changes in
cytosolic calcium have been shown to be important for SFK activa-
tion by a number of stimulants in different cells [25,52]. However,
activation of SFK in granulocytes is not dependent on PKC activation
[52] and bombesin activation of Src pathway in 3T3 cells is calcium-
independent [25]. These results support the conclusion that the im-
portance of activation the two limbs of PLC in activating SFKs varies
in different cells.
In pancreatic acini [2,7,9,28,43,53] and also in other cells [1],
SFKs are important in modulating activation of a number of cellular
signaling cascades involved in different cellular functions such as
secretion, endocytosis, growth, cytoskeletal integrity and apoptosis.
However, the speciﬁc Src isoform mediating the effect is usually un-
known because there are no speciﬁc inhibitors/activators for the dif-
ferent SFKs. In some cases, SFKs are able to associate and interact
directly with a wide range of substrates, such as kinases, cytoskele-
tal and structural proteins, adapters and receptors. An assessment of
these associations can be used to determine the speciﬁc interaction
with SFKs with different cellular signaling cascades in pancreatic
acini [2,7,9,28,43,53] and also in other cellular systems [1]. Acti-
vated SFKs are reported to directly associate with focal adhesion ki-
nases (p125FAK, PYK2) [1,24,25], paxillin [1], p130CAS [1], PKC-δ [1],
PI3-kinase [1], Shc [1,28] and Cbl [1]. Our results using speciﬁc Yes
co-immunoprecipitation experiments, demonstrate that TPA and
CCK at both physiological and supramaximal concentrations, stimu-
late the association of Yes with a number of cellular signaling cas-
cades including with focal adhesion kinases, PKCδ, Shc, p130Cas,
PI3K, PTEN and PKD, but not with Cbl or Erk 1/2. A previous study
[13] in pancreatic acini of Pyk-2 and p125FAK, demonstrated that
CCK and TPA stimulate tyrosine phosphorylation differentially at
three of their most important regulatory sites. Our study demon-
strates that CCK, as well as TPA, stimulates an association of Yes
with each of their speciﬁc autophosphorylated forms (pY397
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portant in their activation. These results are similar to previous ob-
servations in pancreatic acini [9,43] or other tissues [25,54,55], but
differ from another study in rat pancreatic acinar cells in which
the association of Yes with FAK was not observed [7]. Our ﬁndings
of direct interactions of Yes with a number of important cell signal-
ing molecules have similarities and differences with other studies of
SFKs in pancreatic acini and other tissues. These results are similar
to ﬁndings in pancreatic acini with the SFK, Lyn in that both CCK/
TPA stimulated its association with PKC-δ, Shc, p125FAK and Pyk-2,
however, in contrast with Yes they differ from our results with
Yes in that no direct interaction of Lyn with p130CAS or PI3K was
detected [9]. In our study the failure to stimulate an association of
Yes with ERK 1/2 was not due to lack of stimulation by CCK of this
signaling pathway in pancreatic acini, because previous studies dem-
onstrate that CCK activates this pathway in pancreatic acinar cells
under similar experimental conditions to those used in our study
[23]. Our results suggest that activation of the SFK, Yes, could play
an important role in CCK activation of MAP kinase in pancreatic
acini, because CCK stimulated both an association of Yes with Shc
as well as with Pyk2, each of which activates MAP kinases [12].
These results are similar to activation of a number of G-protein-
coupled-receptors which have been shown to stimulate MAP kinases
by a SFK dependentmechanism [44], and similar to results in pancre-
atic cell lines in which activation of CCK receptors stimulated a com-
plex formation of Yes with Shc [28]. In pancreatic acini CCK also
stimulates in a Src-dependent manner, the translocation, activation
and tyrosine phosphorylation of PKCδ [6]. This activation of PKCδ
stimulates NFk-B activity [56], which has been shown to be impor-
tant in the development of pancreatitis. Our results raise the possi-
bility that the SFK, Yes, could be involved together with Lyn [9] in
this process, because in both cases, CCK stimulated the association
of these SFKs with PKCδ. Similarly in other cell systems the associa-
tion of PKCδ with other SFKs is seen with different stimulants
[6,57,58]. However, these results differ from ﬁndings in PC-12 cells
and parotid cells [59], where neither TPA nor carbachol stimulated
the association of PKC-δ and Src, although each activated PKC-δ
[6,57]. Our results with a lack of stimulated interaction of Cbl with
Yes differ from those in several studies where an association between
SFKs members and Cbl has been demonstrated [60,61] and this interac-
tion can be a mechanism of activation of PI3K [60,61]. However, unlike
the SFK Lyn, [9], CCK and TPA stimulated an association between Yes
and PI3K, which suggests that Yes activation may be important for the
PI3K activation through amechanism different than the Cbl interaction.
In conclusion, this study demonstrates that in rat pancreatic acini
the SFK, Yes is present and is activated by CCK and other gastrointes-
tinal hormones/neurotransmitters that activate phospholipase C sig-
naling cascade, but not by pancreatic growth factors. The activation
of Yes by CCK, is very rapid, requires stimulation of both limbs of
the phospholipase C pathway (calcium and PKC) and is mediated by
activation of both high and low CCK1 receptor afﬁnity states. This re-
sults in the direct association of Yes with a number of important CCK
signaling cascades including focal adhesion kinases Pyk-2 and
p125FAK, PKCδ, Shc, p130Cas, PI3K, PTEN and PKD. These results sup-
port the conclusion that activation of the SFK Yes plays a central
role in activating pancreatic signaling cascades which have been
shown to be important for mediating CCK changes in acinar cell func-
tion (growth, apoptosis, secretion). The results suggest that the Src
kinase Yes in pancreatic acini may be one of the important pancreatic
SFKs mediating many of the physiological and pathophysiological
roles of SFKs described in numerous studies.
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